Pediatric phase I trial design using maximum target inhibition as the primary endpoint.

Source:http://linkedlifedata.com/resource/pubmed/id/20460632

J. Natl. Cancer Inst. 2010 Jun 16 102 12 909-12

Download in:

View as

General Info

PMID
20460632